Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis

Pediatric Pulmonology

Volumn 52, Issue 3, 2017, Pages 324-330

  Bouso, Jennifer M ^a,b   Burns, James J ^a   Amin, Raid ^c   Livingston, Floyd R ^b   Elidemir, Okan ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b NEMOURS CHILDREN S CLINIC   (United States)

^c UNIVERSITY OF WEST FLORIDA   (United States)

Author keywords

atypical mycobacteria; children; cystic fibrosis; infections (pneumonia TB viral); infectious disease; nontuberculous mycobacteria; pediatric pulmonology; water

Indexed keywords

WATER; FRESH WATER;

ARTICLE; ASPERGILLUS FUMIGATUS; ATYPICAL MYCOBACTERIUM; BAY; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FLORIDA; GEOGRAPHIC INFORMATION SYSTEM; HOUSING; HUMAN; LAKE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM SIMIAE; POND; PSEUDOMONAS AERUGINOSA; RIVER; SEA; ADOLESCENT; ALABAMA; ASPERGILLOSIS; DEMOGRAPHY; MICROBIOLOGY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDY;

ADOLESCENT; ALABAMA; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CHILD; CYSTIC FIBROSIS; FEMALE; FLORIDA; FRESH WATER; GEOGRAPHIC INFORMATION SYSTEMS; HUMANS; MALE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; OCEANS AND SEAS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES;

EID: 85011681225     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23646     Document Type: Article

References (40)

1. Martiniano SL, Nick JA, Daley CL. Nontuberculous mycobacterial infections in cystic fibrosis. Clin Chest Med 2016; 37:83–96.
2. Faro A. Pulmonary disease in cystic fibrosis. In: Bush A, Wilmott R, Chernick V, Boat T, Ratjen F, Deterding R, editors. Kendig & chernick's disorders of the respiratory tract in children. Philadelphia, PA: Elsevier; 2012. pp 770–780.
3. Ashbolt NJ. Environmental (Saprozoic) pathogens of engineered water systems: understanding their ecology for risk assessment and management. Pathogens 2015; 4:390–405.
4. Parkins MD, Floto RA. Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis. J Cyst Fibros 2015; 14:293–304.
5. Ramsay KA, Stockwell RE, Bell SC, Kidd TJ. Infection in cystic fibrosis: impact of the environment and climate. Expert Rev Respir Med 2016; 10:505–519.
6. Whittaker LA, Teneback C. Atypical mycobacterial and fungal infections in cystic fibrosis. Semin Respir Crit Care Med 2009; 30:539–546.
7. Smith MJ, Efthimiou J, Hodson ME, Batten JC. Mycobacterial isolations in young adults with cystic fibrosis. Thorax 1984; 39:369–375.
8. Raidt L, Idelevich EA, Dübbers A, Küster P, Drevinek P, Peters G, Kahl BC. Increased prevalence and resistance of important pathogens recovered from respiratory specimens of cystic fibrosis patients during a decade. Pediatr Infect Dis J 2015; 34:700–705.
9. Adjemian J, Olivier KN, Prevots DR. Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk. Am J Respir Crit Care Med 2014; 190:581–586.
10. Bar-On O, Mussaffi H, Mei-Zahav M, Prais D, Steuer G, Stafler P, Hananya S, Blau H. Increasing nontuberculous mycobacteria infection in cystic fibrosis. J Cyst Fibros 2015; 14:53–62.
11. Olivier KN, Weber DJ, Wallace RJ, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, and others. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003; 167:828–834.
12. Esther CR, Henry MM, Molina PL, Leigh MW. Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatr Pulmonol 2005; 40:39–44.
13. Esther CR, Esserman DA, Gilligan P, Kerr A, Noone PG. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros 2010; 9:117–123.
14. Olivier KN, Weber DJ, Lee JH, Handler A, Tudor G, Molina PL, Tomashefski J, Knowles MR. Group NMiCFS. Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med 2003; 167:835–840.
15. Park IK, Olivier KN. Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis. Semin Respir Crit Care Med 2015; 36:217–224.
16. Verregghen M, Heijerman HG, Reijers M, van Ingen J, van der Ent CK. Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case-control study. J Cyst Fibros 2012; 11:340–343.
17. Viviani L, Harrison MJ, Zolin A, Haworth CS, Floto RA. Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF). J Cyst Fibros 2016; 15:619–623.
18. Binder AM, Adjemian J, Olivier KN, Prevots DR. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. Am J Respir Crit Care Med 2013; 188:807–812.
19. Catherinot E, Roux AL, Vibet MA, Bellis G, Ravilly S, Lemonnier L, Le Roux E, Bernède-Bauduin C, Le Bourgeois M, Herrmann JL, and others. Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. J Cyst Fibros 2013; 12:74–80.
20. Coolen N, Morand P, Martin C, Hubert D, Kanaan R, Chapron J, Honoré I, Dusser D, Audureau E, Veziris N, and others. Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin. J Cyst Fibros 2015; 14:594–599.
21. Leung JM, Olivier KN. Nontuberculous mycobacteria in patients with cystic fibrosis. Semin Respir Crit Care Med 2013; 34:124–134.
22. Mussaffi H, Rivlin J, Shalit I, Ephros M, Blau H. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J 2005; 25:324–328.
23. Radhakrishnan DK, Yau Y, Corey M, Richardson S, Chedore P, Jamieson F, Dell SD. Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors. Pediatr Pulmonol 2009; 44:1100–1106.
24. Jennifer A, Kenneth NO, Prevots DR. Predictors of Prolonged Nontuberculous Mycobacterial Infections in Patients with Cystic Fibrosis. C105. NONTUBERCULOUS MYCOBACTERIA EPIDEMIOLOGY, American Thoracic Society International Conference Abstracts: American Thoracic Society; 2015. p A5255–A5255.
25. Catherinot E, Roux AL, Vibet MA, Bellis G, Lemonnier L, Le Roux E, Bernède-Bauduin C, Le Bourgeois M, Herrmann JL, Guillemot D, and others. Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients. Eur Respir J 2013; 41:1101–1106.
26. Adjemian J, Olivier KN, Seitz AE, Falkinham JO, Holland SM, Prevots DR. Spatial clusters of nontuberculous mycobacterial lung disease in the United States. Am J Respir Crit Care Med 2012; 186:553–558.
27. Jennifer A, Alison MB, Kenneth NO, Prevots DR. Nontuberculous Mycobacterial Disease Among Cystic Fibrosis Patients In The United States: Environmental Risk And NTM Screening Practices. C17. CYSTIC FIBROSIS LUNG INFECTIONS, American Thoracic Society International Conference Abstracts: American Thoracic Society; 2014. p A3955–A3955.
28. Prevots DR, Adjemian J, Fernandez AG, Knowles MR, Olivier KN. Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population. Ann Am Thorac Soc 2014; 11:1032–1038.
29. Goeminne PC, Nawrot TS, De Boeck K, Nemery B, Dupont LJ. Proximity to blue spaces and risk of infection with Pseudomonas aeruginosa in cystic fibrosis: a case-control analysis. J Cyst Fibros 2015; 14:741–747.
30. Fradelos EC, Papathanasiou IV, Mitsi D, Tsaras K, Kleisiaris CF, Kourkouta L. Health based geographic information systems (GIS) and their applications. Acta Inform Med 2014; 22:402–405.
31. Parker BC, Ford MA, Gruft H, Falkinham JO. Epidemiology of infection by nontuberculous mycobacteria. IV. Preferential aerosolization of Mycobacterium intracellulare from natural waters. Am Rev Respir Dis 1983; 128:652–656.
32. Falkinham JO. Ecology of nontuberculous mycobacteria-where do human infections come from? Semin Respir Crit Care Med 2013; 34:95–102.
33. Falkinham JO. Environmental sources of nontuberculous mycobacteria. Clin Chest Med 2015; 36:35–41.
34. Bryant JM, Grogono DM, Greaves D, Foweraker J, Roddick I, Inns T, Reacher M, Haworth CS, Curran MD, Harris SR, and others. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet 2013; 381:1551–1560.
35. Böttger EC. Transmission of M abscessus in patients with cystic fibrosis. Lancet 2013; 382:503–504.
36. Falkinham JO. Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment. J Appl Microbiol 2009; 107:356–367.
37. Falkinham JO, Parker BC, Gruft H. Epidemiology of infection by nontuberculous mycobacteria. I. Geographic distribution in the eastern United States. Am Rev Respir Dis 1980; 121:931–937.
38. Gaffen D, Ross R. Climatology and trends of U.S. surface humidity and temperature. J Clim 1999; 12:811–828.
39. Martiniano SL, Sontag MK, Daley CL, Nick JA, Sagel SD. Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. Ann Am Thorac Soc 2014; 11:36–44.
40. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, and others. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367–416.